Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Cresco Labs ( (TSE:CL) ) just unveiled an announcement.
Cresco Labs announced it will release its full-year and fourth-quarter 2025 financial results on March 5, 2026, before the market opens, followed by an earnings conference call and webcast for investors. The planned disclosure underscores the company’s ongoing communication with the market and offers stakeholders insight into its operational performance and brand strategy execution in the competitive U.S. cannabis sector.
The call will provide key business highlights and will be accessible live and via an archived webcast on the Cresco Labs investor relations website for one year. This extended access is intended to increase transparency and engagement with shareholders and analysts, potentially informing views on Cresco’s growth trajectory, retail footprint under the Sunnyside brand and its positioning among leading multi-state cannabis operators.
The most recent analyst rating on (TSE:CL) stock is a Hold with a C$1.50 price target. To see the full list of analyst forecasts on Cresco Labs stock, see the TSE:CL Stock Forecast page.
Spark’s Take on TSE:CL Stock
According to Spark, TipRanks’ AI Analyst, TSE:CL is a Neutral.
Cresco Labs’ overall stock score is primarily impacted by its financial performance challenges, including declining revenues and high leverage. Technical analysis shows moderate strength, while valuation remains weak due to negative profitability metrics. The earnings call provided some positive insights into strategic expansions and debt refinancing, but ongoing market challenges and operational adjustments weigh on the outlook.
To see Spark’s full report on TSE:CL stock, click here.
More about Cresco Labs
Cresco Labs Inc. is a U.S.-based cannabis company specializing in branded cannabis products and customer-focused retail through its Sunnyside dispensaries. The company operates as a leader in cultivation, production and national distribution of consumer packaged goods-style cannabis brands such as Cresco, High Supply, FloraCal, Good News, Wonder Wellness Co., Mindy’s and Remedi, while also engaging in legislative, regulatory and community initiatives to shape a responsible cannabis industry.
YTD Price Performance: -6.02%
Average Trading Volume: 318,532
Technical Sentiment Signal: Strong Sell
Current Market Cap: C$609.5M
For detailed information about CL stock, go to TipRanks’ Stock Analysis page.